Dhanvantri Jeevan Rekha vs HCA Healthcare: Fair Value & Quality
Both stocks run through our valuation models. Here is how Dhanvantri Jeevan Rekha (ZDHJERK) and HCA Healthcare (HCA) compare, as of Aug 21, 2026.
As of Aug 21, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dhanvantri Jeevan Rekha trades at ₹25.89 versus a fair value of ₹16.59 (-36%), while HCA Healthcare trades at $406 versus $548 (+35%).
Dhanvantri Jeevan Rekha
ZDHJERK.BSE · INR · Health Care
-36%
upside to fair value
overvalued
Price₹25.89
Fair Value₹16.59
Quality59/100
HCA Healthcare
HCA · USD · Health Care
+35%
upside to fair value
undervalued
Price$406
Fair Value$548
Quality70/100
Get comparisons like this free by email every month: the most undervalued quality stocks.
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Dhanvantri Jeevan RekhaHCA Healthcare
Valuation
27.5×P/E (TTM)14.1×
0.42×P/S (TTM)1.06×
1.03×P/B—
6.7×EV/EBITDA7.8×
—PEG1.18×
—Dividend yield0.7%
—Dividend per share$2.94
Profitability
2%Net margin9%
4%Operating margin15%
4%Return on equity136%
2%Return on assets12%
Growth
24%Revenue growth (YoY)4%
13.5%Avg. growth/yr (3Y)7.9%
21.5%Avg. growth/yr (5Y)8.0%
Balance & size
$1MMarket cap$81B
healthyGrowth qualityhealthy
Even match: 5 to 5 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Dhanvantri Jeevan Rekhaof which business quality 61 · market factors 54HCA Healthcareof which business quality 66 · market factors 39
ProfitabilityMargins and returns on capital today
55
76
Quality GrowthAre margins and returns improving?
32
61
CashflowEarnings quality: real cash, not paper profit
InvestmentDisciplined investing over empire-building
77
75
Low VolatilityCalm price path (market factor)
60
59
MomentumPrice trend over the last 3–12 months (market factor)
49
29
52W MomentumDistance to the 52-week high (market factor)
57
35
Net IssuanceBuybacks instead of dilution
82
100
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Dhanvantri Jeevan Rekha
DCF Models₹36.73
Earnings-Based₹12.77
Multiples₹16.59
Asset-Based₹17.18
Growth DCF₹30.28
Economic Profit₹13.08
Growth Earnings₹20.03
15 of 24 models see the stock below the current price.
HCA Healthcare
DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506
6 of 23 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Dhanvantri Jeevan Rekha
Bear ₹12.44Fair Value ₹16.59Bull ₹20.74
₹25.89 = current price (white tick)
HCA Healthcare
Bear $260Fair Value $548Bull $841
$406 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Free, no sign-up
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Dhanvantri Jeevan Rekha · Health Care
Quality score59 · above median
Fair value upside-36% · below median
HCA Healthcare · Health Care
Quality score70 · Top 25%
Fair value upside+35% · Top 25%
Bottom line
As of Aug 21, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Dhanvantri Jeevan Rekha trades at ₹25.89 versus a fair value of ₹16.59 (-36%), while HCA Healthcare trades at $406 versus $548 (+35%).
HCA Healthcare has the higher quality score (70/100).
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.